.Lung Therapy Specialist – Johnson & Johnson Innovative Medicines UK Location: Field Based – x1 North and x1 South UK Janssen is recruiting x2 Lung Therapy Specialists (with some additional responsibility in Precision Medicine) to be based within our UK Operating Company within a field-based role. Key Responsibilities: To clinically promote J&J; Cancer Therapy medicines across prioritised Integrated Care Systems and Cancer Alliance footprints ensuring optimised appropriate patient access. Your primary role as a Therapy Specialist will be to lead the business plan for implementation within NHS Trusts and other defined local accounts as agreed with Business Leaders.In Hospital Trusts and other agreed system customers you will deliver specific tactics to support appropriate local uptake of medicines in agreement with your Strategic Access Manager (SAM) and National Sales Manager (NSM). You will also clinically promote J&J; Cancer medicines in wider parts of Integrated Care System to ensure patient uptake of and access to J&J; Medicines is optimised.Other ICS system stakeholders could include Primary Care Network (PCN) Cancer customers and/or Cancer Locality Groups dependent on the Strategic Account Plan agreed with your SAM/NSM. A detailed and in-depth understanding of NHS Trust health priorities, local NHS Trust Pathways and inter-connectivity of the patient journey to other system pathways will be a core requirement to inform effective business planning & customer engagement. As a Therapy Specialist, you will be responsible for: Initially Clinical Promotion for J&J; Lung medicine in the private sector and launch readiness planning across Bladder Cancer and also for precision medicine (FGRF testing for bladder cancer disease area mapping and planning, and mapping across different formulations of lung disease).Ø Map and prioritise the likely adoption flow of NHS Hospitals. Ø Ensure readiness for adoption onto hospital formulary on day of launch. Ø Build relationships with regional clinical leaders across Lung Cancer and Bladder Cancer Ø Drive early use of in our new indications with aim to leverage this experience at the appropriate time in an NHS launch. Ø Prepare launch mapping for different types of formulation launch in Lung Cancer and Bladder Cancer understanding fully the needs of each key account from a service and implementation perspective. Ø Engage with SAM/SS/MSL to advance plans and connections to Cancer Alliance and Genomic Hubs where appropriate. Ø Create, validate target lists across key footprints Clinical Promotion & Scientific Knowledge (Licensed Indications ONLY)Drive clinical demand for brands & defined indications as a priority through execution of brand strategy & key tactics in-field. Confident and capable to deliver assertive, and balanced clinical arguments to positively challenge behaviours/status quo to influence clinicians to drive prescribing behavioural change
